【英語論文】

①Isogaya Y,Kezuka D, Suzuki C, Hoshina S, andSuzuki E. Impact of the COVID-19 pandemic on patients with bipolar disorder in Japan. Psychiatry Clin. Neurosci. Rep. 2023; 2: e82.
https://doi.org/10.1002/pcn5.82

②Yamada K, Usui K, andSuzuki E. Severe adverse reactions caused by Kampo formulas from the viewpoint of cases relieved by the Adverse Drug Reaction Relief System in 2021. Traditional & Kampo Medicine. 2023https://doi.org/10.1002/tkm2.1378

③ Usui K, Kikuchi D, Otsuka N, Miyagi K, Ouchi R, Watanabe T, Okada K, andSuzuki E. Hypnotic prescriptions in Japan may be shifting from benzodiazepine receptor agonists to other types of hypnotics, melatonin receptor agonists, and orexin receptor antagonists. Psychiatry Clin. Neurosci. Rep. 2023; 2: e113.
https://doi.org/10.1002/pcn5.113

④Fukuchi N, Shigemura J, and Obara A. The Support to Mitigate the Impact of Suicide for Disaster Aid Workers of the 2011 Great East Japan Earthquake. Disaster Medicine and Public Health Preparedness, 2023; 17, E517.
https://doi.org/10.1017/dmp.2023.169